The potential for liquid biopsies in the precision medical treatment of breast cancer

Currently the clinical management of breast cancer relies on relatively few prognostic/predictive clinical markers (estrogen receptor, progesterone receptor, HER2), based on primary tumor biology. Circulating biomarkers, such as circulating tumor DNA (ctDNA) or circulating tumor cells (CTCs) may enh...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Cancer Biol Med
Glavni autori: Forte, Victoria A., Barrak, Dany K., Elhodaky, Mostafa, Tung, Lily, Snow, Anson, Lang, Julie E.
Format: Artigo
Jezik:Inglês
Izdano: Chinese Anti-Cancer Association 2016
Teme:
Review
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4850125/
https://ncbi.nlm.nih.gov/pubmed/27144060
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.28092/j.issn.2095-3941.2016.0007
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items